FINDEX Inc. (TYO:3649)
Japan · Delayed Price · Currency is JPY | Market Cap | 22.65B -4.7% |
| Revenue (ttm) | 6.11B +4.6% |
| Net Income | 1.26B +8.2% |
| EPS | 50.07 +10.6% |
| Shares Out | 24.41M |
| PE Ratio | 18.53 |
| Forward PE | 17.15 |
| Dividend | 27.00 (3.02%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 137,900 |
| Average Volume | 161,245 |
| Open | 894.00 |
| Previous Close | 894.00 |
| Day's Range | 881.00 - 930.00 |
| 52-Week Range | 598.00 - 1,011.00 |
| Beta | 0.31 |
| RSI | 55.44 |
| Earnings Date | Feb 12, 2026 |
About FINDEX
FINDEX Inc. offers medical systems, office systems, and medical equipment solutions in Japan. It operates through three segments: Medical Business, Public Business, and Healthtech Business. The company provides Claio image filing system, C-Scan paper and digital document management system, DocuMaker document creation system, PDI+MoveBy referral information management system, C-Note medical record writing system, MapleNote perinatal system, REMORA electronic medical record, ID-Cam/Claio-Cam digital camera solution, UniversalSearcher medical big ... [Read more]
Financial Performance
In 2025, FINDEX's revenue was 6.11 billion, an increase of 4.60% compared to the previous year's 5.84 billion. Earnings were 1.26 billion, an increase of 8.17%.
Financial StatementsNews
PE-backed Findex set to restock coffers with $400m refinancing
Skye Capital is expected to spend the coming weeks collecting feedback from funds on the deal structure, including size and pricing.